The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease

BACKGROUND: Numerous pre-clinical studies and clinical trials demonstrated that induction of antibodies to the β-amyloid peptide of 42 residues (Aβ(42)) elicits therapeutic effects in Alzheimer's disease (AD). However, an active vaccination strategy based on full length Aβ(42 )is currently hamp...

Descripción completa

Detalles Bibliográficos
Autores principales: Davtyan, Hayk, Ghochikyan, Anahit, Cadagan, Richard, Zamarin, Dmitriy, Petrushina, Irina, Movsesyan, Nina, Martinez-Sobrido, Luis, Albrecht, Randy A, García-Sastre, Adolfo, Agadjanyan, Michael G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162512/
https://www.ncbi.nlm.nih.gov/pubmed/21806809
http://dx.doi.org/10.1186/1479-5876-9-127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162512/
https://www.ncbi.nlm.nih.gov/pubmed/21806809
http://dx.doi.org/10.1186/1479-5876-9-127

Ejemplares similares